M. R. Charney

5% amlexanox oral paste, a new treatment for recurrent minor aphthous ulcers: II. Pharmacokinetics and demonstration of clinical safety.

R. V. Van Inwegen, A. Khandwala, M. Alfano, 1997, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: A 1‐year Phase 1/2 clinical trial

R. Schiffmann, R. Colvin, O. Goker-Alpan, 2019, Journal of inherited metabolic disease.

Effects of application durations and heat on the pharmacokinetic properties of drug delivered by a lidocaine/tetracaine patch: a randomized, open-label, controlled study in healthy volunteers.

M. R. Charney, T. Marriott, S. Stanworth, 2012, Clinical therapeutics.

Tolerability, Gut Effects, and Pharmacokinetics of Methylnaltrexone Following Repeated Intravenous Administration in Humans

T. Karrison, C. Yuan, J. Moss, 2005, Journal of clinical pharmacology.